Moderna (MRNA)

Capital Expenditure

-$37.00M

Quarterly · Period ending: · USD

MRNA logo

MRNA Capital Expenditure

Latest reported-$37.00M
MRNA Quarterly CapEx (-$8.67M → -$37.00M)
High-resolution chart · PNG

MRNA capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-37,000,000
-62,000,000
-39,000,000
-33,000,000
-3,000,000
-127,000,000
-522,000,000
-151,000,000
-182,000,000
-196,000,000
-220,000,000
-140,000,000
-234,000,000
-113,000,000
-92,000,000
-89,000,000
-87,000,000
-132,000,000
-120,000,000
-99,000,000
-30,000,000
-35,000,000
-23,301,000
-19,292,000
-18,632,000
-6,223,000
-6,662,000
-6,711,000
-10,586,000
-7,595,000
-13,637,000
-26,140,000
-34,080,000
-31,909,000
-11,960,000
-29,098,000
-8,671,500
-8,671,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.